top of page
>
>
Assess the biosimilars market and create a medical affairs strategy to prepare for biosimilar launches
Client Problems
A large biopharmaceutical company wants to assess the regulatory and clinical biosimilars market to enable informed treatment decision making in the best interest of patients
What We Did
-
Developed a U.S. biosimilars landscape and identified the key events and policy changes
-
Created a comprehensive MCL and MSL training plan
-
Conduct an on-site workshop to identify the Key Medical Objectives gaps and develop new tactics
Our Results And Insight
Explore Biosimilars Landscape
MSL / MCL training support
Realign teams and stakeholders. Describe scope of action
See other case studies
Operation Strategy case studies >
Oncology case studies >
Service Areas Details
Operation Strategy (medical affairs)
Therapeutic Areas Details
Oncology (immunoncology)
Featured Consultants
Diana Starr
bottom of page